J Oncol Pharm Pract
June 2022
Introduction: Filgrastim is a granulocyte colony-stimulating factor (GSCF) used in some chemotherapy regimen to prevent febrile neutropenia. Most common reaction of filgrastim are aches and pain including headaches, nausea and skin rash.
Case Report: We report the case of a patient who developed unusual, non-commonly reported adverse toxidermy to filgrastim.
Introduction: Colorectal cancer (CRC) is at present the third most common malignancy in the world. With changes in lifestyle its incidence and mortality have increased during last decades.
Aim: To explore the association between red meat, processed meat and risk of colorectal cancer.
COVID-19 is an exceptional public healthcare emergency that affected all countries. The corona virus pandemic has made the treatment of all cancers difficult. This international phenomenon represents an outbreak in medicine and this situation is a major issue for all patients, whether they are infected with the virus or not.
View Article and Find Full Text PDFProstate cancer is the second most frequent among men. Bones and lymph nodes are the most common sites of metastases in advanced prostate cancer. Oral cavity metastases are rare.
View Article and Find Full Text PDF